Yale-New Haven Medical Center Neuromuscular Medicine (Neurology)

Topics

• Myasthenia Gravis and Thymoma 79
• Peripheral Neuropathies and Disorders 25
• Amyotrophic Lateral Sclerosis Research 19
• Diabetes Treatment and Management 16
• Inflammatory Myopathies and Dermatomyositis 16
• Cerebral Venous Sinus Thrombosis 13
• Diet and metabolism studies 11
• Intracranial Aneurysms: Treatment and Complications 11
• Long-Term Effects of COVID-19 11
• Acute Ischemic Stroke Management 10
• Alzheimer's disease research and treatments 8
• Innovations in Medical Education 7

Most cited

1. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study.

   The Lancet. Neurology · 2025 · 76 citations · Richard Nowak

2. A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.

   The New England journal of medicine · 2025 · 51 citations · Richard Nowak

3. Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study

   Neurology · 2024 · 66 citations · Richard Nowak

4. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.

   Stroke · 2022 · 121 citations · Adeel Zubair

5. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.

   Stroke · 2024 · 48 citations · Adeel Zubair

6. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.

   Nature medicine · 2022 · 128 citations · Frank Diaz